Scarica l'app Stockscreener
3.695
0.68%
0.025
Precedente Chiudi:
$3.67
Aprire:
$3.66
Volume 24 ore:
184.74K
Relative Volume:
0.44
Capitalizzazione di mercato:
$315.79M
Reddito:
$351.37M
Utile/perdita netta:
$-174.01M
Rapporto P/E:
-1.785
EPS:
-2.07
Flusso di cassa netto:
$-126.94M
1 W Prestazione:
-1.20%
1M Prestazione:
+2.64%
6M Prestazione:
+20.75%
1 anno Prestazione:
-3.27%
Intervallo 1D:
$3.625
$3.8091
Intervallo di 1 settimana:
$3.625
$4.02
Portata 52W:
$2.455
$4.145
Atea Pharmaceuticals Inc Stock (AVIR) Company Profile
Nome
Atea Pharmaceuticals Inc
Settore
Industria
Telefono
857-204-8109
Indirizzo
225 FRANKLIN STREET, BOSTON
Confronta AVIR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AVIR
Atea Pharmaceuticals Inc
|
3.69 | 325.20M | 351.37M | -174.01M | -126.94M | -2.07 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.46 | 120.29B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
548.35 | 60.26B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
389.20 | 43.10B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
672.73 | 36.65B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
300.38 | 33.09B | 3.81B | -644.79M | -669.77M | -6.24 |
Atea Pharmaceuticals Inc Stock (AVIR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-08-13 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
| 2023-08-10 | Downgrade | JP Morgan | Neutral → Underweight |
| 2022-01-06 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2021-11-18 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2021-10-20 | Downgrade | JP Morgan | Overweight → Neutral |
| 2021-10-05 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-11-25 | Iniziato | Evercore ISI | Outperform |
| 2020-11-24 | Iniziato | JP Morgan | Overweight |
| 2020-11-24 | Iniziato | Morgan Stanley | Overweight |
| 2020-11-24 | Iniziato | William Blair | Outperform |
Mostra tutto
Atea Pharmaceuticals Inc Borsa (AVIR) Ultime notizie
Atea Pharmaceuticals to Host Second Quarter 2025 Financial - GlobeNewswire
Atea Pharmaceuticals Sets Q2 Earnings Date: Key Updates Expected on Antiviral Drug Pipeline - Stock Titan
Regression analysis insights on Atea Pharmaceuticals Inc. performanceAI Pattern Recognition and Trade Prediction - Newser
Using data filters to optimize entry into Atea Pharmaceuticals Inc.Historical Stock Summary and ROI Review - Newser
What makes Atea Pharmaceuticals Inc. stock price move sharplyFree Access to Smart Investment Tips - Newser
Is Atea Pharmaceuticals Inc. a Top Dividend Stock to Watch in 2025Free Momentum Based Equity Trading Plan - Newser
Quantitative breakdown of Atea Pharmaceuticals Inc. recent moveFundamental Forecast for Undervalued Stocks - Newser
Custom watchlist performance reports with Atea Pharmaceuticals Inc.ROI Focused Setup Screener With Exit Markers - Newser
Institutional scanner results for Atea Pharmaceuticals Inc.Watchlist Generator With Real-Time Entry - Newser
Published on: 2025-07-29 16:38:14 - Newser
Atea Pharmaceuticals Inc. Company’s Quarterly Earnings Growth: What the Numbers SayReal-Time Investment Signal Forecast with AI - Newser
Fibonacci Support Holding Strong in Atea Pharmaceuticals Inc.Real Time Trade Opportunity Alerts Monitor Market Surges - metal.it
Long term hold vs stop loss in Atea Pharmaceuticals Inc.Free Swing Trading Plan With Smart Signals - Newser
Candlestick Reversal Detected on Atea Pharmaceuticals Inc.’s ChartOversold Recovery Opportunity Stocks Attract Buyers - metal.it
Why Atea Pharmaceuticals Inc. stock attracts strong analyst attentionTrend Reversal Watch with Entry Signals - Newser
Is Atea Pharmaceuticals Inc. Forming a Consolidation BaseSwing Trading Plan With Smart Signals in Review - metal.it
Is Atea Pharmaceuticals Inc. a growth stock or a value stockMarket Forecast Picks That Work - jammulinksnews.com
Atea Pharmaceuticals Inc. Price Targets Raised After ReboundTechnical Stock Breakout Predictions Signal Entry Points - metal.it
What institutional investors are buying Atea Pharmaceuticals Inc. stockDiscover top stock picks for aggressive growth - jammulinksnews.com
Institutional scanner results for Atea Pharmaceuticals Inc. Free Daily Smart Money Movement Monitor - Newser
How volatile is Atea Pharmaceuticals Inc. stock compared to the marketTriple-digit profit margins - jammulinksnews.com
How does Atea Pharmaceuticals Inc. compare to its industry peersDouble-digit growth - jammulinksnews.com
When is Atea Pharmaceuticals Inc. stock expected to show significant growthUnlock powerful portfolio optimization tools - jammulinksnews.com
What drives Atea Pharmaceuticals Inc. stock priceExceptional earning trajectories - PrintWeekIndia
What analysts say about Atea Pharmaceuticals Inc. stockSuperior risk-adjusted returns - PrintWeekIndia
What risks could impact Atea Pharmaceuticals Inc. stock performanceHigh-yield capital appreciation - jammulinksnews.com
3 Promising Penny Stocks With A Market Cap Of At Least $200M - simplywall.st
What analysts say about Atea Pharmaceuticals Inc. stock outlookHigh-velocity gains - jammulinksnews.com
Will Atea Pharmaceuticals Inc. stock benefit from interest rate changesExceptional profit margins - jammulinksnews.com
Atea Pharmaceuticals Insiders Placed Bullish Bets Worth US$5.40m - Yahoo Finance
Atea Pharmaceuticals Inc. Stock Analysis and ForecastDynamic investment growth - jammulinksnews.com
Is Atea Pharmaceuticals Inc. a good long term investmentPhenomenal wealth increase - jammulinksnews.com
Atea Pharmaceuticals Inc Azioni (AVIR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Atea Pharmaceuticals Inc Azioni (AVIR) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| BERGER FRANKLIN M | Director |
Jun 20 '25 |
Option Exercise |
0.00 |
29,600 |
0 |
506,497 |
| Duncan Barbara Gayle | Director |
Jun 20 '25 |
Option Exercise |
0.00 |
29,600 |
0 |
62,750 |
| Polsky Bruce | Director |
Jun 20 '25 |
Option Exercise |
0.00 |
29,600 |
0 |
95,206 |
| Adams Jerome M. | Director |
Jun 20 '25 |
Option Exercise |
0.00 |
29,600 |
0 |
62,750 |
| Lucidi Bruno | Director |
Jun 20 '25 |
Option Exercise |
0.00 |
29,600 |
0 |
112,750 |
| BERGER FRANKLIN M | Director |
Dec 10 '24 |
Sale |
2.85 |
359,606 |
1,023,475 |
451,897 |
3.06%
1.72%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):